Clinical Trials Logo

Speech Perception clinical trials

View clinical trials related to Speech Perception.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06237790 Recruiting - Hearing Loss Clinical Trials

A Comparative Analysis of Speech Perception Between Cochlear Implant Patients and DFNB9 Patients Receiving Gene Therapy

Start date: April 6, 2024
Phase:
Study type: Observational

This cohort study aims to explore the trends and differences in multidimensional perceptual levels of patients after cochlear implants or gene therapy, as well as to comprehensively assess the efficacy of gene therapy for congenital deafness, thus providing a reference for making a well-rounded postoperative rehabilitation protocol for gene therapy patients.

NCT ID: NCT05653999 Recruiting - Hearing Loss Clinical Trials

Assessing Speech Perception and Amplification Benefit During Infancy

Start date: March 10, 2023
Phase:
Study type: Observational

The goal of this project is to compare aided and unaided speech discrimination among infants with hearing loss and a cohort of infants with typical hearing. Working Hypothesis: Among this group of infants with hearing loss, performance will be significantly better when infants are tested while using amplification (i.e., aided condition) compared to when tested without amplification (i.e., unaided condition). Infants fit with optimally programmed amplification will perform similarly to the infants with typical hearing on speech discrimination tasks.

NCT ID: NCT04762043 Recruiting - Speech Disorders Clinical Trials

MyoVoice to Restore Natural, Hands-free Communication to Individuals With Vocal Impairments

Start date: February 12, 2021
Phase: N/A
Study type: Interventional

This study will evaluate the ability of MyoVoice to replace natural speech. Referred to generally as an Augmentative and Alternative Communication (AAC) device, MyoVoice uses electrical signals recorded non-invasively from speech muscles (electromyographic, or EMG, signals) to restore communication for those with vocal impairments that resulted from surgical treatment of laryngeal and oropharyngeal cancers.